INCYTE CORPORATION
NASDAQ: INCY (Incyte Corporation)
Kemas kini terakhir: 4 jam lalu100.46
-1.04 (-1.02%)
| Penutupan Terdahulu | 101.50 |
| Buka | 101.20 |
| Jumlah Dagangan | 1,982,410 |
| Purata Dagangan (3B) | 2,134,053 |
| Modal Pasaran | 19,722,577,920 |
| Harga / Pendapatan (P/E TTM) | 17.03 |
| Harga / Pendapatan (P/E Ke hadapan) | 13.39 |
| Harga / Jualan (P/S) | 4.25 |
| Harga / Buku (P/B) | 4.29 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Oct 2025 |
| Margin Keuntungan | 0.48% |
| Margin Operasi (TTM) | 20.65% |
| EPS Cair (TTM) | 0.200 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 19.50% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -6.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 1.18% |
| Nisbah Semasa (MRQ) | 2.04 |
| Aliran Tunai Operasi (OCF TTM) | 382.59 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 618.05 M |
| Pulangan Atas Aset (ROA TTM) | 2.04% |
| Pulangan Atas Ekuiti (ROE TTM) | 0.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Incyte Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | 0.0 |
| Volatiliti Harga | -1.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 0.5 |
| Purata | 0.00 |
|
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 2.01% |
| % Dimiliki oleh Institusi | 100.65% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Baker Bros. Advisors Lp | 30 Sep 2025 | 30,743,663 |
| Robeco Institutional Asset Management B.V. | 30 Sep 2025 | 2,319,388 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 125.00 (Guggenheim, 24.43%) | Beli |
| Median | 99.50 (-0.96%) | |
| Rendah | 84.00 (RBC Capital, -16.39%) | Pegang |
| Purata | 102.50 (2.03%) | |
| Jumlah | 5 Beli, 3 Pegang | |
| Harga Purata @ Panggilan | 93.84 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Barclays | 24 Nov 2025 | 115.00 (14.47%) | Beli | 106.24 |
| 29 Oct 2025 | 101.00 (0.54%) | Beli | 90.18 | |
| Piper Sandler | 04 Nov 2025 | 102.00 (1.53%) | Beli | 102.92 |
| Guggenheim | 03 Nov 2025 | 125.00 (24.43%) | Beli | 101.57 |
| RBC Capital | 29 Oct 2025 | 84.00 (-16.38%) | Pegang | 90.18 |
| 24 Sep 2025 | 81.00 (-19.37%) | Pegang | 84.16 | |
| Truist Securities | 29 Oct 2025 | 93.00 (-7.43%) | Pegang | 90.18 |
| Wells Fargo | 29 Oct 2025 | 97.00 (-3.44%) | Beli | 90.18 |
| JP Morgan | 09 Oct 2025 | 89.00 (-11.41%) | Pegang | 84.75 |
| Stifel | 22 Sep 2025 | 115.00 (14.47%) | Beli | 84.73 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HOFFMAN RICHARD A. | 102.04 | - | 9,466 | 965,911 |
| MORRISSEY MICHAEL JAMES | - | 102.04 | -326 | -33,265 |
| STEIN STEVEN H | - | 101.84 | -39,757 | -4,044,741 |
| TRAY THOMAS | - | 104.15 | -769 | -80,992 |
| Jumlah Keseluruhan Kuantiti Bersih | -31,386 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -3,193,088 | |||
| Purata Pembelian Keseluruhan ($) | 102.04 | |||
| Purata Jualan Keseluruhan ($) | 102.64 | |||
| Julat Insider ($) | ||||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| STEIN STEVEN H | Pegawai | 02 Dec 2025 | Jual (-) | 20,105 | 101.44 | 2,039,451 |
| HOFFMAN RICHARD A. | Pegawai | 01 Dec 2025 | Diperolehi (+) | 9,466 | 102.04 | 965,911 |
| MORRISSEY MICHAEL JAMES | Pegawai | 01 Dec 2025 | Dibuang (-) | 326 | 102.04 | 33,265 |
| STEIN STEVEN H | Pegawai | 01 Dec 2025 | Jual (-) | 2,559 | 102.04 | 261,120 |
| STEIN STEVEN H | Pegawai | 01 Dec 2025 | Dibuang (-) | 17,093 | 102.04 | 1,744,170 |
| TRAY THOMAS | Pegawai | 24 Nov 2025 | Jual (-) | 600 | 106.24 | 63,744 |
| TRAY THOMAS | Pegawai | 21 Nov 2025 | Jual (-) | 169 | 102.06 | 17,248 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |